FY26 Results: Revenue Jumps 17%, but Profits & Cash Flow Tumble
Anuh Pharma Ltd · ANUHPHR · BSE ·
📈 **Revenue from Operations** grew 16.65% YoY to ₹771.66 Cr. 📉 **Profit After Tax (PAT)** declined by 13.32% YoY to ₹41.05 Cr, with EBITDA margins contracting sharply by 208 bps. 💰 **Dividend**: The Board has recommended a final dividend of ₹1.50 per share (30% payout). 🔴 **M…